4.5 Review

IL-2 and its high-affinity receptor: Genetic control of immunoregulation and autoimmunity

Journal

SEMINARS IN IMMUNOLOGY
Volume 21, Issue 6, Pages 363-371

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.smim.2009.04.004

Keywords

Type 1 diabetes; Immunogenetics; IL-2; IL-2RA; CD4+CD25+Tregs; Immunoregulation

Categories

Funding

  1. Canadian Institutes of Health Research
  2. JDRF
  3. Wellcome Trust
  4. Canadian Diabetes Association
  5. Diabetes Association (Foothills)

Ask authors/readers for more resources

Type 1 diabetes (T1D) is an organ-specific autoimmune disease featured by destruction of the insulin producing beta-cells of the pancreas by autoreactive T-lymphocytes. Putative environmental triggers conspire with a constellation of genetic elements scattered throughout the genome to elicit a multifactorial autoimmune response involving virtually every cell type of the immune system against pancreatic beta-cells. Recent highly powered genome-wide association studies have confirmed and identified fifteen chromosomal regions harboring several candidate T1D-associated gene loci. Here, we summarize what we know about the genetics of T1D with an emphasis on the contributions of mouse IL2 and human IL2RA polymorphisms and the IL-2-IL-2R pathway to autoimmunity and, more specifically, Treg development and function. (C) 2009 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available